Standout Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis 2023 2026 2024145
  1. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis (2023)
    Geert D’Haens, Marla C. Dubinsky et al. New England Journal of Medicine

Immediate Impact

68 standout
Sub-graph 1 of 20

Citing Papers

Polysaccharides with antioxidant activity: Extraction, beneficial roles, biological mechanisms, structure-function relationships, and future perspectives: A review
2025 Standout
Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
6 intermediate papers

Works of Janelle Laskowski being referenced

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
2019

Author Peers

Author Last Decade Papers Cites
Janelle Laskowski 197 284 37 126 7 344
Francisco Fidencio Cons Molina 234 283 22 118 7 408
Willem-Jan Wollants 163 282 24 142 9 392
Aurada Cholapranee 190 233 29 69 6 319
Makoto Yamamura 139 192 13 107 11 330
D. J. Buurman 154 240 27 152 8 331
O Squarcia 215 292 27 138 8 377
Takashi Shimoyama 142 222 14 178 10 353
Sarah Caspersen 239 277 17 66 5 349
Lindsey Sattler 182 261 24 95 7 352
Maren Stahl 151 200 19 49 9 368

All Works

Loading papers...

Rankless by CCL
2026